Abstract
In Petten two lines of BNCT research are conducted, one aiming at the development and construction of a clinical facility at the High Flux Reactor (1–3), and the other one studying the fundamental aspects of BNCT (3–5). For both lines the measurement of boron concentrations play a crucial role. The precondition for the clinical application of BNCT, high boron concentration in tumour cells and low concentration in normal tissue, requires insight in the pharmacokinetics of the boron compound. To understand the fundamental mechanism of BNCT, knowledge about the macroscopic distribution of boron within a tumour volume and the microscopic distribution at the cellular level are needed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.L. Moss et al., Proceedings of the Fourth International Symposium on Neutron Capture Therapy for Cancer, Sydney December 1990, contribution 2.3, to be published
L. Dewit et al., ibid, contribution 18.1
D. Gabel, ibid, contribution 11.2
R. Huiskamp et al., ibid, contribution 12A1
V.G.A. Gregoire et al., ibid, contribution 14A3
F. Stecher-Rasmussen et al., Nucl. Phys. A181 (1972) 225
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Konijnenberg, M. et al. (1992). Boron Concentration Measurements for the Petten BNCT Project. In: Allen, B.J., Moore, D.E., Harrington, B.V. (eds) Progress in Neutron Capture Therapy for Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3384-9_63
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3384-9_63
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6494-8
Online ISBN: 978-1-4615-3384-9
eBook Packages: Springer Book Archive